BRIEF-Enveric Biosciences Reports Positive Preclinical Results For Lead Drug Candidate EB-003

Reuters
28 May
BRIEF-<a href="https://laohu8.com/S/ENVB">Enveric Biosciences</a> Reports Positive Preclinical Results For Lead Drug Candidate EB-003

May 28 (Reuters) - Enveric Biosciences Inc ENVB.O:

  • ENVERIC BIOSCIENCES REPORTS POSITIVE PRECLINICAL RESULTS FOR LEAD DRUG CANDIDATE EB-003

  • ENVERIC BIOSCIENCES INC - SUPPORT FOR SAFE EXTENDED DAILY ORAL ADMINISTRATION

  • ENVERIC BIOSCIENCES INC - SIGNIFICANT IMPROVEMENTS IN SEVERE CHRONIC DEPRESSION MODEL

Source text: ID:nBw7xbqwva

Further company coverage: ENVB.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10